Dr. J. Joseph Kim, CEO at Inovio Pharmaceuticals, discusses vaccine development for COVID-19. Kim points out that there's been "a lot of incremental successes" in phase one trials. He also talks about the importance of ensuring safety and efficacy.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.